SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: POLETO who wrote (61666)3/15/1999 12:29:00 PM
From: Michaelste  Read Replies (2) of 119973
 
POSS **NEWS** FDA Approval and confidence.

Possis Medical FDA OK -3: Device Called Alternative To Drugs

In its press release Monday, the FDA said the Coronary Angiojet Rheolytic thrombectomy
system "will provide an alternative treatment to so-called clot-busting drugs, and will
be particularly useful for patients in whom these drugs cannot be used."
The FDA described the device as a coronary catheter system that "shoots a jet of
saline solution back into the tip of the catheter to suck out blood clots."
Treatment with the Coronary AngioJet Rheolytic thrombectomy system takes about one
minute, and afterwards, patients can undergo angioplasty to remove the blockage in the
artery.
The system was already approved to treat blood clots in dialysis grafts.
The agency said the device was approved based on studies of 731 patients in the U.S.
and Canada.
-Otesa Middleton contributed to this report.
(END) DOW JONES NEWS 03-15-99
12:20 PM
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News